Compared with the model, CSBTA (75 and 100 mg/kg) significantly reduced liver ALT, AST, Hyp, MDA, TGF-β1, and MMP-9 levels, and up-regulated decreased TP, ALB, SOD contents in the hepatic fibrosis rats. The gene discussed is SOD1; the disease is Hepatic fibrosis.